306 related articles for article (PubMed ID: 7477801)
1. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa--binge-eating/purging type.
Brambilla F; Draisci A; Peirone A; Brunetta M
Neuropsychobiology; 1995; 32(2):64-7. PubMed ID: 7477801
[TBL] [Abstract][Full Text] [Related]
2. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 1. Anorexia nervosa--restricted type.
Brambilla F; Draisci A; Peirone A; Brunetta M
Neuropsychobiology; 1995; 32(2):59-63. PubMed ID: 7477800
[TBL] [Abstract][Full Text] [Related]
3. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in bulimia nervosa.
Brambilla F; Draisci A; Peirone A; Brunetta M
Neuropsychobiology; 1995; 32(2):68-71. PubMed ID: 7477802
[TBL] [Abstract][Full Text] [Related]
4. An open trial of fluoxetine for adolescents with bulimia nervosa.
Kotler LA; Devlin MJ; Davies M; Walsh BT
J Child Adolesc Psychopharmacol; 2003; 13(3):329-35. PubMed ID: 14642021
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and acceptability of amineptine versus fluoxetine in major depression.
Dalery J; Rochat C; Peyron E; Bernard G
Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S35-8. PubMed ID: 9347391
[TBL] [Abstract][Full Text] [Related]
6. Medication and psychotherapy in the treatment of bulimia nervosa.
Walsh BT; Wilson GT; Loeb KL; Devlin MJ; Pike KM; Roose SP; Fleiss J; Waternaux C
Am J Psychiatry; 1997 Apr; 154(4):523-31. PubMed ID: 9090340
[TBL] [Abstract][Full Text] [Related]
7. Short-term course of depressive symptoms in patients with eating disorders.
Wamboldt FS; Kaslow NJ; Swift WJ; Ritholz M
Am J Psychiatry; 1987 Mar; 144(3):362-4. PubMed ID: 3469919
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial and pharmacological treatment of eating disorders: a review of research findings.
Peterson CB; Mitchell JE
J Clin Psychol; 1999 Jun; 55(6):685-97. PubMed ID: 10445860
[TBL] [Abstract][Full Text] [Related]
9. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
Palavras MA; Hay P; Touyz S; Sainsbury A; da Luz F; Swinbourne J; Estella NM; Claudino A
Trials; 2015 Dec; 16():578. PubMed ID: 26683478
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.
Ricca V; Mannucci E; Mezzani B; Moretti S; Di Bernardo M; Bertelli M; Rotella CM; Faravelli C
Psychother Psychosom; 2001; 70(6):298-306. PubMed ID: 11598429
[TBL] [Abstract][Full Text] [Related]
11. Objective and subjective binge eating in underweight eating disorders: associated features and treatment outcome.
Dalle Grave R; Calugi S; Marchesini G
Int J Eat Disord; 2012 Apr; 45(3):370-6. PubMed ID: 21656542
[TBL] [Abstract][Full Text] [Related]
12. Management of eating disorders.
Berkman ND; Bulik CM; Brownley KA; Lohr KN; Sedway JA; Rooks A; Gartlehner G
Evid Rep Technol Assess (Full Rep); 2006 Apr; (135):1-166. PubMed ID: 17628126
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive-behavioral treatment in patients with bulimia nervosa.
Tanaka M; Nakahara T; Muranaga T; Kojima S; Yasuhara D; Ueno H; Nakazato M; Inui A
Horm Behav; 2006 Aug; 50(2):261-5. PubMed ID: 16643914
[TBL] [Abstract][Full Text] [Related]
14. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
Devlin MJ; Goldfein JA; Petkova E; Jiang H; Raizman PS; Wolk S; Mayer L; Carino J; Bellace D; Kamenetz C; Dobrow I; Walsh BT
Obes Res; 2005 Jun; 13(6):1077-88. PubMed ID: 15976151
[TBL] [Abstract][Full Text] [Related]
15. The use of citalopram in an integrated approach to the treatment of eating disorders: an open study.
Calandra C; Gulino V; Inserra L; Giuffrida A
Eat Weight Disord; 1999 Dec; 4(4):207-10. PubMed ID: 10728184
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine dependence in a former amineptine abuser.
Taïeb O; Larroche C; Dutray B; Baubet T; Moro MR
Am J Addict; 2004; 13(5):498-500. PubMed ID: 15764428
[No Abstract] [Full Text] [Related]
17. Postremission predictors of relapse in women with eating disorders.
Keel PK; Dorer DJ; Franko DL; Jackson SC; Herzog DB
Am J Psychiatry; 2005 Dec; 162(12):2263-8. PubMed ID: 16330589
[TBL] [Abstract][Full Text] [Related]
18. Out of control! the most effective way to help the binge-eating patient.
McGown A; Whitbread J
J Psychosoc Nurs Ment Health Serv; 1996 Jan; 34(1):30-7. PubMed ID: 8720013
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up.
Devlin MJ; Goldfein JA; Petkova E; Liu L; Walsh BT
Obesity (Silver Spring); 2007 Jul; 15(7):1702-9. PubMed ID: 17636088
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression.
Goldstein DJ; Wilson MG; Ascroft RC; al-Banna M
Int J Eat Disord; 1999 Jan; 25(1):19-27. PubMed ID: 9924649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
